Filing Details

Accession Number:
0001209191-10-047435
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-09-24 13:33:09
Reporting Period:
2010-09-23
Filing Date:
2010-09-24
Accepted Time:
2010-09-24 13:33:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103390 Ardea Biosciences Inc. RDEA Pharmaceutical Preparations (2834) 943200380
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1286100 John Poyhonen 4939 Directors Place
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-09-23 4,000 $5.85 4,000 No 4 M Direct
Common Stock Disposition 2010-09-23 4,000 $23.02 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2010-09-23 4,000 $0.00 4,000 $5.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,000 2017-06-14 No 4 M Direct
Footnotes
  1. Immediately exercisable, subject to a right of repurchase on behalf of the Issuer that lapses ratably over the 36 months following the grant date.